283 related articles for article (PubMed ID: 37685286)
1. Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities.
Kourti M; Aivaliotis M; Hatzipantelis E
Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685286
[TBL] [Abstract][Full Text] [Related]
2. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities.
Tran TH; Hunger SP
Semin Cancer Biol; 2022 Sep; 84():144-152. PubMed ID: 33197607
[TBL] [Abstract][Full Text] [Related]
3. Proteomic tools and new insights for the study of B-cell precursor acute lymphoblastic leukemia.
Citalan-Madrid AF; Cabral-Pacheco GA; Martinez-de-Villarreal LE; Villarreal-Martinez L; Ibarra-Ramirez M; Garza-Veloz I; Cardenas-Vargas E; Marino-Martinez I; Martinez-Fierro ML
Hematology; 2019 Dec; 24(1):637-650. PubMed ID: 31514680
[TBL] [Abstract][Full Text] [Related]
4. Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.
Lejman M; Chałupnik A; Chilimoniuk Z; Dobosz M
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269896
[TBL] [Abstract][Full Text] [Related]
5. Advances in next-generation sequencing for relapsed pediatric acute lymphoblastic leukemia: current insights and future directions.
Mohd Nippah NF; Abu N; Ab Mutalib NS; Alias H
Front Genet; 2024; 15():1394523. PubMed ID: 38894724
[TBL] [Abstract][Full Text] [Related]
6. Individualized therapy for childhood acute lymphoblastic leukemia.
Raetz EA; Bhojwani D; Min DJ; Carroll WL
Per Med; 2005 Nov; 2(4):349-361. PubMed ID: 29788576
[TBL] [Abstract][Full Text] [Related]
7. Genomic and proteomic characterization of Philadelphia-like B-lineage acute lymphoblastic leukemia: A report of Indian patients.
Gupta DG; Varma N; Kumar A; Naseem S; Sachdeva MUS; Sreedharanunni S; Binota J; Bose P; Khadwal A; Malhotra P; Varma S
Cancer; 2023 Apr; 129(8):1217-1226. PubMed ID: 36738086
[TBL] [Abstract][Full Text] [Related]
8. Label-free quantitative proteomics reveals differentially expressed proteins in high risk childhood acute lymphoblastic leukemia.
Xu G; Li Z; Wang L; Chen F; Chi Z; Gu M; Li S; Wu D; Miao J; Zhang Y; Hao L; Fan Y
J Proteomics; 2017 Jan; 150():1-8. PubMed ID: 27569049
[TBL] [Abstract][Full Text] [Related]
9. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells.
Kanderova V; Kuzilkova D; Stuchly J; Vaskova M; Brdicka T; Fiser K; Hrusak O; Lund-Johansen F; Kalina T
Mol Cell Proteomics; 2016 Apr; 15(4):1246-61. PubMed ID: 26785729
[TBL] [Abstract][Full Text] [Related]
10. PDX models reflect the proteome landscape of pediatric acute lymphoblastic leukemia but divert in select pathways.
Uzozie AC; Ergin EK; Rolf N; Tsui J; Lorentzian A; Weng SSH; Nierves L; Smith TG; Lim CJ; Maxwell CA; Reid GSD; Lange PF
J Exp Clin Cancer Res; 2021 Mar; 40(1):96. PubMed ID: 33722259
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of childhood leukemia.
Hegedus CM; Gunn L; Skibola CF; Zhang L; Shiao R; Fu S; Dalmasso EA; Metayer C; Dahl GV; Buffler PA; Smith MT
Leukemia; 2005 Oct; 19(10):1713-8. PubMed ID: 16136170
[TBL] [Abstract][Full Text] [Related]
12. High-throughput proteomics and AI for cancer biomarker discovery.
Xiao Q; Zhang F; Xu L; Yue L; Kon OL; Zhu Y; Guo T
Adv Drug Deliv Rev; 2021 Sep; 176():113844. PubMed ID: 34182017
[TBL] [Abstract][Full Text] [Related]
13. The epigenome in pediatric acute lymphoblastic leukemia: drug resistance and therapeutic opportunities.
Meyer LK; Hermiston ML
Cancer Drug Resist; 2019; 2(2):313-325. PubMed ID: 35582725
[TBL] [Abstract][Full Text] [Related]
14. Insight from mitochondrial functions and proteomics to understand cardiometabolic disorders in survivors of acute lymphoblastic leukemia.
Leahy J; Spahis S; Bonneil E; Garofalo C; Grimard G; Morel S; Laverdière C; Krajinovic M; Drouin S; Delvin E; Sinnett D; Marcil V; Levy E
Metabolism; 2018 Aug; 85():151-160. PubMed ID: 29563052
[TBL] [Abstract][Full Text] [Related]
15. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications.
Jimenez CR; Verheul HM
Am Soc Clin Oncol Educ Book; 2014; ():e504-10. PubMed ID: 24857147
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
18. Proteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunities.
López Villar E; Wu D; Cho WC; Madero L; Wang X
J Cell Mol Med; 2014 Jul; 18(7):1239-46. PubMed ID: 24912534
[TBL] [Abstract][Full Text] [Related]
19. [Precision medicine and molecular target drugs in pediatric hematologic malignancies: acute lymphoblastic leukemia].
Takita J
Rinsho Ketsueki; 2020; 61(6):657-664. PubMed ID: 32624540
[TBL] [Abstract][Full Text] [Related]
20. High-throughput proteomics of breast cancer subtypes: Biological characterization and multiple candidate biomarker panels to patients' stratification.
Azevedo ALK; Gomig THB; Batista M; Marchini FK; Spautz CC; Rabinovich I; Sebastião APM; Oliveira JC; Gradia DF; Cavalli IJ; Ribeiro EMSF
J Proteomics; 2023 Aug; 285():104955. PubMed ID: 37390896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
